Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Artivion, Inc. stock logo
AORT
Artivion
$20.14
-3.4%
$30.43
$19.16
$48.25
$976.69M1.26977,980 shs554,932 shs
CONMED Corporation stock logo
CNMD
CONMED
$35.07
-0.2%
$36.44
$32.13
$60.35
$1.06B0.92440,698 shs420,238 shs
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
$9.35
-9.1%
$8.59
$2.82
$11.62
$844.55M1.191.25 million shs1.39 million shs
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
$1.08
-8.5%
$1.09
$0.70
$14.11
$196.35M1.851.69 million shs1.32 million shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Artivion, Inc. stock logo
AORT
Artivion
-3.20%-9.50%-42.01%-45.84%-29.66%
CONMED Corporation stock logo
CNMD
CONMED
-0.21%-1.94%-6.11%-12.58%-37.97%
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
-8.69%-13.67%+23.19%+45.87%+218.03%
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
-8.47%-28.48%+6.93%-45.73%+107,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Artivion, Inc. stock logo
AORT
Artivion
$20.14
-3.4%
$30.43
$19.16
$48.25
$976.69M1.26977,980 shs554,932 shs
CONMED Corporation stock logo
CNMD
CONMED
$35.07
-0.2%
$36.44
$32.13
$60.35
$1.06B0.92440,698 shs420,238 shs
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
$9.35
-9.1%
$8.59
$2.82
$11.62
$844.55M1.191.25 million shs1.39 million shs
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
$1.08
-8.5%
$1.09
$0.70
$14.11
$196.35M1.851.69 million shs1.32 million shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Artivion, Inc. stock logo
AORT
Artivion
-3.20%-9.50%-42.01%-45.84%-29.66%
CONMED Corporation stock logo
CNMD
CONMED
-0.21%-1.94%-6.11%-12.58%-37.97%
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
-8.69%-13.67%+23.19%+45.87%+218.03%
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
-8.47%-28.48%+6.93%-45.73%+107,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Artivion, Inc. stock logo
AORT
Artivion
2.88
Moderate Buy$46.17129.25% Upside
CONMED Corporation stock logo
CNMD
CONMED
1.86
Reduce$43.8024.91% Upside
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
2.43
Hold$12.6034.76% Upside
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
2.00
Hold$8.00640.74% Upside

Current Analyst Ratings Breakdown

Latest STEX, AORT, CNMD, and DRTS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/4/2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
Boost Price TargetOverweight$15.00 ➝ $17.00
6/2/2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
Reiterated RatingBuy$15.00
6/1/2026
Artivion, Inc. stock logo
AORT
Artivion
Set Price Target$45.00
5/28/2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
Initiated CoverageOverweight$15.00
5/28/2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
Initiated CoverageOverweight$15.00
5/21/2026
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
Lower Price TargetBuy$9.00 ➝ $8.00
5/20/2026
Artivion, Inc. stock logo
AORT
Artivion
Reiterated RatingHold (C-)
5/20/2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
Reiterated RatingBuy$15.00
5/19/2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
Boost Price TargetNeutral$5.00 ➝ $8.00
5/18/2026
CONMED Corporation stock logo
CNMD
CONMED
Lower Price TargetNeutral$52.00 ➝ $40.00
5/12/2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
Boost Price TargetBuy$12.00 ➝ $14.00
(Data available from 6/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Artivion, Inc. stock logo
AORT
Artivion
$441.33M2.21$1.10 per share18.26$9.46 per share2.13
CONMED Corporation stock logo
CNMD
CONMED
$1.37B0.77$7.19 per share4.88$33.36 per share1.05
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
N/AN/AN/AN/A$0.88 per shareN/A
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
$40K4,908.60N/AN/A$0.83 per share1.30
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Artivion, Inc. stock logo
AORT
Artivion
$9.77M$0.2430.9526.85N/A2.55%7.15%3.63%8/6/2026 (Estimated)
CONMED Corporation stock logo
CNMD
CONMED
$47.06M$1.7719.817.261.734.00%13.84%6.05%7/29/2026 (Estimated)
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
-$42.63M-$0.67N/AN/AN/AN/A-73.23%-52.90%8/10/2026 (Estimated)
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
-$462.77M-$9.71N/AN/AN/AN/A-717.92%-336.75%N/A

Latest STEX, AORT, CNMD, and DRTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/18/2026Q1 2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
-$0.13-$0.26-$0.13-$0.26$0.05 millionN/A
5/14/2026Q1 2026
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
N/A-$0.27N/A-$0.27N/AN/A
4/29/2026Q1 2026
CONMED Corporation stock logo
CNMD
CONMED
$0.82$0.89+$0.07$0.45$310.64 million$317.05 million
3/31/2026Q4 2025
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
N/A-$8.23N/A-$8.23N/AN/A
3/9/2026Q4 2025
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
-$0.13-$0.14-$0.01-$0.92$0.06 millionN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Artivion, Inc. stock logo
AORT
Artivion
N/AN/AN/AN/AN/A
CONMED Corporation stock logo
CNMD
CONMED
N/AN/A-5.59%N/AN/A
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
N/AN/AN/AN/AN/A
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Artivion, Inc. stock logo
AORT
Artivion
0.48
3.86
2.80
CONMED Corporation stock logo
CNMD
CONMED
0.85
2.29
1.04
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
0.09
7.79
7.79
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
N/A
13.90
13.90

Institutional Ownership

CompanyInstitutional Ownership
Artivion, Inc. stock logo
AORT
Artivion
86.37%
CONMED Corporation stock logo
CNMD
CONMED
N/A
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
2.65%
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
7.16%

Insider Ownership

CompanyInsider Ownership
Artivion, Inc. stock logo
AORT
Artivion
6.30%
CONMED Corporation stock logo
CNMD
CONMED
0.28%
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
39.50%
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
52.73%
CompanyEmployeesShares OutstandingFree FloatOptionable
Artivion, Inc. stock logo
AORT
Artivion
1,80048.54 million45.49 millionOptionable
CONMED Corporation stock logo
CNMD
CONMED
3,90030.11 million30.03 millionOptionable
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
8090.33 million54.65 millionNo Data
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
50181.80 million85.94 millionN/A

Recent News About These Companies

Biosig Technologies Q1 Earnings Call Highlights
Streamex Corp. Provides May 2026 Shareholder Update
Streamex Corp. (STEX) Q4 2025 Earnings Call Transcript
Streamex Corp.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Artivion stock logo

Artivion NYSE:AORT

$20.14 -0.70 (-3.37%)
Closing price 06/5/2026 03:59 PM Eastern
Extended Trading
$20.12 -0.02 (-0.09%)
As of 06/5/2026 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

CONMED stock logo

CONMED NYSE:CNMD

$35.06 -0.07 (-0.19%)
Closing price 06/5/2026 03:59 PM Eastern
Extended Trading
$34.76 -0.31 (-0.88%)
As of 06/5/2026 04:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Alpha Tau Medical stock logo

Alpha Tau Medical NASDAQ:DRTS

$9.35 -0.94 (-9.14%)
Closing price 06/5/2026 04:00 PM Eastern
Extended Trading
$9.66 +0.32 (+3.37%)
As of 06/5/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Biosig Technologies stock logo

Biosig Technologies NASDAQ:STEX

$1.08 -0.10 (-8.47%)
Closing price 06/5/2026 04:00 PM Eastern
Extended Trading
$1.06 -0.02 (-1.39%)
As of 06/5/2026 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.